Pregled bibliografske jedinice broj: 1161860
Gastric cancer detection using the serum pepsinogen test method
Gastric cancer detection using the serum pepsinogen test method // Tumori, 108 (2021), 4; 386-391 doi:10.1177/03008916211014961 (međunarodna recenzija, članak, ostalo)
CROSBI ID: 1161860 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Gastric cancer detection using the serum pepsinogen
test method
Autori
Trivanović, Dragan ; Pleština, Stjepko ; Honović, Lorena ; Dobrila-Dintinjana Renata ; Vlašić Tanasković Jelena ; Vrbanec Damir
Izvornik
Tumori (0300-8916) 108
(2021), 4;
386-391
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, ostalo
Ključne riječi
Pepsinogen ; gastric cancer ; serologic biopsy ; sensitivity ; specificity
(Pepsinogen, ; gastric cancer ; serologic biopsy ; sensitivity ; specificity)
Sažetak
Abstract Background: Gastric cancer (GC) is the eighth most common cause of cancer deaths in Croatia and one of the most common causes of cancer deaths worldwide. A reliable diagnostic tool for the early detection of GC is essential. Objective: We previously suggested a pepsinogen test method to reduce the mortality from GC by allowing early detection. Here, we report an updated analysis from a prospective single-center clinical study to evaluate the sensitivity and specificity of the pepsinogen test method and to determine whether this test can be used as a part of routine laboratory assessment of high-risk patients. Methods: We present mature data of the pepsinogen test method in the Croatian population after a median follow-up of 36 months. Statistical analyses were performed using a Mann-Whitney U test, multiple logistic regression, and receiver operating characteristics (ROC) to evaluate the predictive power of the assayed biomarkers. Results: Of the 116 patients, 25 patients had GC and 91 demonstrated a nonmalignant pathology based on tissue biopsy. Cutoff values were pepsinogen I ⩽70 and pepsinogen I/II ratio ⩽3.0. Using ROC curve analysis, the accuracy, sensitivity, specificity, positive predictive value, and negative predictive value were determined to be 87.22%, 78.12%, 90.10%, 71.43%, and 92.86%, respectively, for the diagnosis of GC. The area under the curve was 0.700 (95% confidence interval 0.57-0.83). Conclusion: Pepsinogen tests are valuable for screening a population in need of further diagnosis and could help to avoid unnecessary invasive endoscopic procedures.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Rijeka,
Medicinski fakultet, Zagreb,
Opća bolnica Pula,
Klinički bolnički centar Zagreb,
Klinički bolnički centar Rijeka
Profili:
Damir Vrbanec
(autor)
Stjepko Pleština
(autor)
Lorena Honović
(autor)
Dragan Trivanović
(autor)
Renata Dobrila-Dintinjana
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE